Structures by: Kaaz M.
Total: 5
1-(1,3-bis(2,6-diisopropylphenyl)-1,3,2-diazaborolen-2-yl)- N,N,N',N'-tetramethylphosphanediamine
C30H48BN4P
Dalton transactions (Cambridge, England : 2003) (2014) 43, 2 680-689
a=17.9692(13)Å b=10.7572(9)Å c=17.2353(14)Å
α=90.00° β=114.004(2)° γ=90.00°
2-(1,3-bis(2,6-diisopropylphenyl)-1,3,2-diazaborolen-2-yl)- 1,3-di-tert-butyl-1,3,2-diazaphospholene
C36H56BN4P
Dalton transactions (Cambridge, England : 2003) (2014) 43, 2 680-689
a=11.7029(8)Å b=12.3599(8)Å c=24.3641(18)Å
α=90.00° β=96.785(3)° γ=90.00°
2-(1,3-bis(2,6-diisopropylphenyl)-1,3,2-diazaborolen-2-yl)- 1,3-bis(2,6-dimethylphenyl)-1,3,2-diazaphospholene
C44H56BN4P
Dalton transactions (Cambridge, England : 2003) (2014) 43, 2 680-689
a=12.4257(4)Å b=12.4802(5)Å c=13.2635(5)Å
α=97.682(2)° β=98.396(2)° γ=103.761(2)°
1,3-bis(2,6-diisopropylphenyl)-2-(phenylphosphanyl)-1,3,2-diazaborolene
C32H42BN2P
Dalton transactions (Cambridge, England : 2003) (2014) 43, 2 680-689
a=12.0947(13)Å b=13.6131(12)Å c=17.9876(14)Å
α=90.00° β=90.00° γ=90.00°
1,3-bis(2,6-diisopropylphenyl)-2-phosphanyl-1,3,2-diazaborolene
C26H38BN2P
Dalton transactions (Cambridge, England : 2003) (2014) 43, 2 680-689
a=7.5063(5)Å b=9.4119(6)Å c=18.3880(14)Å
α=77.441(3)° β=86.774(4)° γ=78.004(3)°